Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Pacira BioSciences specializes in developing and commercializing non-opioid pain management therapies, including long-acting local anesthetics, corticosteroids, and nerve block devices. Its core products—EXPAREL, ZILRETTA, and iovera—serve surgical, orthopedic, and pain relief markets, emphasizing opioid reduction and enhanced recovery. The company leverages proprietary drug delivery and nerve modulation technologies to provide safe, effective, and targeted pain solutions for diverse patient populations.
This description was generated via AI from an annual report. Updated about 1 year ago.